-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation
-
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
Review Article: Clinical Investigation